| 摘要 |
The invention relates to a substance intended to be administered in a deficiency condition resulting in collagen insufficiency in the mesodermal, ectodermal and endodermal tissue, or for the purpose of preventing the aforementioned deficiency condition, and intended to undergo further development as a drug to be used for appropriate indications. The amino acid Lysine, preferably 1-Lysine, is present in the aforementioned substance, and the substance also contains Glycine, preferably 1-Glycine, and Proline, preferably 1-Proline, as a mixture. |
